IRIS
MONTANI, MARIA NADIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.513
AS - Asia 1.856
EU - Europa 1.513
SA - Sud America 181
AF - Africa 57
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.128
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.477
CN - Cina 1.040
SG - Singapore 401
IE - Irlanda 317
UA - Ucraina 246
FI - Finlandia 188
DE - Germania 159
HK - Hong Kong 150
RU - Federazione Russa 148
BR - Brasile 112
IT - Italia 112
VN - Vietnam 108
GB - Regno Unito 94
FR - Francia 89
SE - Svezia 74
IN - India 36
ZA - Sudafrica 29
PL - Polonia 26
AR - Argentina 24
BD - Bangladesh 24
CA - Canada 18
BE - Belgio 16
CO - Colombia 16
IQ - Iraq 16
IR - Iran 16
JP - Giappone 13
EC - Ecuador 10
MX - Messico 10
NL - Olanda 10
ID - Indonesia 9
MU - Mauritius 8
PK - Pakistan 7
VE - Venezuela 7
KE - Kenya 6
ES - Italia 5
LT - Lituania 5
MA - Marocco 5
TR - Turchia 5
AU - Australia 4
CH - Svizzera 4
CL - Cile 4
EG - Egitto 4
RO - Romania 4
CZ - Repubblica Ceca 3
GR - Grecia 3
MY - Malesia 3
PE - Perù 3
PY - Paraguay 3
AL - Albania 2
AZ - Azerbaigian 2
ET - Etiopia 2
EU - Europa 2
HN - Honduras 2
JO - Giordania 2
KZ - Kazakistan 2
LB - Libano 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
OM - Oman 2
PH - Filippine 2
PT - Portogallo 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DJ - Gibuti 1
DM - Dominica 1
GE - Georgia 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
KG - Kirghizistan 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SM - San Marino 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 6.128
Salva come PNG Salva come JPEG
Città #
San Jose 376
Chandler 322
Dublin 315
Jacksonville 298
Nanjing 232
Singapore 219
Ashburn 198
Beijing 166
Hong Kong 147
Dallas 134
Boardman 116
Nanchang 86
Hebei 73
Changsha 72
Ann Arbor 64
Lawrence 64
Princeton 64
Lauterbourg 60
Shenyang 59
Jiaxing 58
Helsinki 53
Wilmington 53
Los Angeles 52
Medford 45
Tianjin 43
Ho Chi Minh City 31
Hangzhou 30
Hanoi 27
Buffalo 25
Johannesburg 25
Moscow 24
New York 24
Munich 23
Woodbridge 22
Des Moines 21
Council Bluffs 19
Brussels 16
Orem 16
Verona 16
Seattle 15
Shanghai 15
Radomsko 14
Tokyo 13
Kunming 12
Milan 12
Warsaw 12
Redondo Beach 11
Chicago 10
Jinan 10
Manchester 10
Poplar 10
Santa Clara 10
Turku 10
Brooklyn 9
Chennai 9
Denver 9
Norwalk 9
Baghdad 8
Dhaka 8
Fairfield 8
San Francisco 8
São Paulo 8
Atlanta 7
Leawood 7
Stockholm 7
Zanjan 7
Zhengzhou 7
Auburn Hills 6
Biên Hòa 6
Mumbai 6
Ningbo 6
Rome 6
Amsterdam 5
Bogotá 5
Boston 5
Da Nang 5
Falkenstein 5
Guangzhou 5
Houston 5
London 5
Montreal 5
Phoenix 5
Quito 5
Taizhou 5
Frankfurt am Main 4
Fuzhou 4
Guayaquil 4
Haiphong 4
Hải Dương 4
Jakarta 4
Lanzhou 4
Mexico City 4
Nairobi 4
Toronto 4
Washington 4
Alexandria 3
Ardabil 3
Bern 3
Cape Town 3
Caracas 3
Totale 4.112
Salva come PNG Salva come JPEG
Nome #
Activation of the haemostatic process in patients with unruptured aortic aneurysm before and after surgical repair 149
Caratteristiche dell'emartro ed evoluzione in artropatia nelle coagulopatie congenite: osservazione su 145 casi afferenti al centro emofilia di Pavia 145
Screening dei difetti dell'emostasi con Platelet Function Analyzer (PFA-100) in donne con meno-metrorragia 143
Acquired von Willebrand syndrome and monoclonal gammopathy: clinical characterization and recovery to infusion of VWF-containing concentrates 134
Abnormalities in thrombin-antithrombin pathway in primary systemic amyloidosis. 133
Atherosclerosis, vascular damage, thrombotic risk factors and congenital bleeding disorders 128
Screening for congenital bleeding disorders with platelet function analyzer (PFA-100) in women with menorrhagia 125
Abnormalities in thrombin-antithrombin pathway in AL amyloidosis. 122
Clotting alterations in primary systemic amyloidosis. 121
L'artropatia e l'emartro ricorrente nelle coagulopatie congenite: l'influenza del trattamento. 121
Activation of the haemostatic process in patients with unruptured aortic aneurysm before and in the first week after surgical repair. 121
Effect of low molecular weight heparin on some markers of platelet and thrombin activation in patients with inflammatory bowel diseasesnresponsive to the standard therapy 117
Platelet function after 'in vivo' and 'in vitro' treatment with thrombolytic agents. 117
Factor V Leiden mutation and risk of thrombotic complications in children treated for lynphoprolipherative diseases 116
Cardiovascular disease, hyperhomocysteinemia and atherothrombotic risk factors in psoriatic patients 114
Bleeding disorders in children with reccurent tonsillitis and prolonged aPTT 114
Long-term evaluation of synovectomy and synoviorthesis on the evolution of joint damage: what's happened after 30 years of follow up? 114
Haemostatic variables, serum lipid abnormalities and vascular complications in diabetes mellitus: a 5 year follow-up study. 110
Efficacy and safety of high doses of FEIBA for major surgery in a patient with haemophilia A and high titre inhibitor 107
Defective anticoagulation system in patients with previous myocardial infarction and residual angina 102
The behaviour of physiologic and acquired anticoagulants in patients with hyperhomocysteinemia and thrombotic complications 102
Patterns of bleeding,comorbidities, and clinical courses in acquired hemophilia A (AHA) and in acquired von Willebrand disease (AVWD): Experience from a single hemophiliaentre in Pavia 100
STUDY OF THREE PATIENTS WITH MONOCLONAL GAMMAPATHIES AND "LUPUS-LIKE" ANTICOAGULANTS. 99
High prevalence of fibrin formation defects in women with menorrhagia and congenital bleeding disorders 99
L'artropatia e l'emartro nelle coagulopatie congenite: l'influenza del trattamento 97
Efficacy and safety of factor VIII inhibitor by-passing activity (FEIBA) in high thrombotic risk patients with acquired haemophilia (AH) Efficacy and safety of factor VIII inhibitor by-passing activity (FEIBA) in high thrombotic risk patients with acquired haemophilia (AH) 97
Performance in sports of children and adolescents with hereditary bleeding disorders 96
Vascular damage, prothrombotic risk factor and trombosis in patients with inherited bleeding disorders 95
Activated prothrombin complex concentrate (FEIBA®) for the treatment and prevention of bleeding in patients with acquired haemophilia: A sequential study 95
Expression of dipeptidylaminopeptidase IV/CD26 in peripheral blood lymphocytes of hemophilic subjects. 94
Clotting alterations in primary systemic amyloidosis 94
Hyperhomocysteinemia and FV ARG 506 GLN in 81 consecutive patients with thrombosis. 93
Malattia di von Willebrand acquisita in 2 pazienti con malattia infiammatoria cronica intestinale 93
PLASMA PROTEIN-Z LEVELS AND HEMOSTASIS IN PATIENTS ON DICUMAROL TREATMENT AND IN PATIENTS WITH BLEEDING TENDENCY OF UNKNOWN ORIGIN 92
Homocysteine plasma levels and vascular damage in congenital clotting factor deficiencies 92
Prevalenza di trombosi arteriose e venose in presenza delle mutazioni G20210A del gene della protrombina e R506Q del gene del FV (Leiden) 91
Bleeding tendency of unknown origin and protein Z levels. 90
Thrombotic markers and mitral valve prolapse in migraine with and without aura at childhood onset 89
Mitral valve prolapse and abnormalities of haemostasis in children and adolescents with migraine with aura and other idiopathic headaches: a pilot study. 89
THROMBOPHILIC SCREENING IN TURNER SYNDROME. 88
Platelet function after in vivo and in vitro treatment with thrombolytic agents 88
Influenza del polimorfismo C677T del gene della MTHFR sui livelli di omocisteina plasmatici e sul rischio trombotico 87
Treatment of bleeding episodes in acquired haemophilia with activated prothrombin complex concentrate: what is the optimal therapy? 87
Purpura Fulminans As Clinical Manifestation of Atypical Sle With Antiphospholipid Antibodies - A Case-report 86
Impaired expression of dipeptidylaminopeptidase IV (DAPN)/CD26 in lymphocytes of hemophiliacs 86
Bleeding tendency in type I neurofibromatosis is related to von Willebrand factor abnormalities 85
Von Willebrand factor/factor VIII behaviour and haemorrhagic manifestations in patients with neurofibromatosis type I 84
Risk of venous thrombosis (VT) and hormonal replacement therapy (HRT) in Turner sindrome 80
Imbalance of oxidant and antioxidant mechanism in ischaemic heart diseases 79
Normalization of homocysteine plasma levels improves the physiological anticoagulation in patients with thromboembolic diseases 79
Prolonged aPTT occasionally detected in children before adenotonsillectomy and bleeding disorders 79
Haemarthroses and arthropathy in mild/moderate haemophilia: data collected from a single Haemophilia Centre, Pavia, Italy 78
Treatment and progression of liver damage in HCV+ haemophiliacs: over 15 years follow up 77
Homocysteine and liver steatosis in HCV infected haemophiliacs 75
Risk factors of thrombosis in poorly controlled inflammatory bowel diseases: benefecial effect of LMW heparin as adjuvant therapy 73
Long-term follow up in Acquired Hemophilia A: clinical courses and outcomes observed in a single Hemophilia Centre 71
Two years prophylaxis with FEIBA and inhibitors levels in a high responder haemophilic patient 70
Modalità di diagnosi e caratteristiche cliniche della M di von Willebrand acquisita 69
Ruolo patogenetico delle alterazioni emocoagulative nell'insorgenza di s poliabortiva e di patologie ostetriche 67
Mitral valve prolapse and abnormalities of haemostasis in children and adolescents with migraine with aura and other idiopathic headaches: a pilot study. 67
Menometrorrhagia in adolescents: is it the first expression of congenital defects of hemostasis 66
Thromboembolic disease and thrombotic risk factors: The effect of treating Hìhyperhomocysteinemia on physiological anticoagulation 66
Haemostasis and low molecular weight heparin (LMWH) therapy in chronic inflammatory bowel diseases (IBD) not responsive to conventional therapy. 64
Study of three patients with monoclonal gammopathies and 'lupus-like' anticoagulants 57
Totale 6.158
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.421
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.421
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022311 10 0 7 6 2 3 14 13 24 13 39 180
2022/2023958 110 65 3 86 110 115 0 48 367 12 29 13
2023/2024253 44 36 14 25 40 54 1 19 4 3 11 2
2024/2025733 11 70 15 24 18 32 12 51 177 14 96 213
2025/20261.961 159 146 178 206 223 79 458 81 150 124 112 45
2026/202718 18 0 0 0 0 0 0 0 0 0 0 0
Totale 6.158